Agenda

Please note: all timings are listed in EST, to view start times in your local timezone, please click here.

  1. Welcome and introduction

    Moderator

    Fourat Muziel Fourat Muziel
    Regulatory & Compliance Analyst, Enhesa Product
  2. Session 1: MoCRA - one year later: How the industry is adapting and addressing implementation
  3. Overview of the U.S. Cosmetics Regulatory Framework: Modernization of Cosmetics Regulation Act (MoCRA)

    • framework for cosmetics regulation in the U.S.;
    • updates on MoCRA; and 
    • future activities under the new authorities. 
    Dr Jannavi Srinivasan Dr Jannavi Srinivasan
    Director, Division of Cosmetics, Office of Cosmetics and Colors (OCAC), U.S. FDA
  4. MoCRA, new requirements and what this means for U.S. cosmetic & personal care companies

    Emily Manoso Emily Manoso
    Executive Vice President, Legal & General Counsel, Personal Care Products Council (PCPC)
  5. MoCRA year two: What’s new, what’s not, and what to expect heading into 2025

    On December 23, 2022, Congress enacted the Modernization of Cosmetics Regulation Act (MoCRA)—the most significant statutory change to the U.S. federal government’s ability to regulate cosmetics since the federal Food, Drug, and Cosmetic Act (FDCA) in 1938.  A year and a half after MoCRA’s enactment, this presentation will cover what beauty companies need to know about: 

    • what’s changed since MoCRA’s enactment;  
    • what’s stayed the same/hasn’t been affected; 
    • what to expect for 2025 as MoCRA continues its rollout; 
    • what’s happening at the state-level?; and
    • how can companies mitigate legal and regulatory risks as a result of MoCRA.
    Kelly Bonner Kelly Bonner
    Associate, Duane Morris LLP
  6. Small business spotlight: Navigating MoCRA from start-up to scale

    • overview on small business exemptions; and 
    • MoCRA compliance: Key consideration for business scaling.
    Meredith Petillo Meredith Petillo
    VP Technical & Regulatory Affairs, Independent Beauty Association (IBA)
  7. Q&A session

  8. Refreshment break

  9. Session 2: State legislative initiatives impacting the cosmetics industry
  10. California's safer consumer products regulations

    • description of California's Safer Consumer Products (SCP) Program;
    • how the SCP program works; and
    • personal care products under evaluation.
    Christine Papagni Christine Papagni
    Supervisor, Product Evaluations Unit, Safer Consumer Products Program, California Department of Toxic Substances Control
  11. California’s cosmetics reporting laws

    • learn about the requirements of the California Safe Cosmetics Act of 2005 (CSCA) and the Cosmetics Fragrance & Flavor Ingredient Right to Know Act of 2020 (CFFIRKA);
    • understand how California’s laws differ from federal reporting requirements; and
    • see highlights from data collected since CFFIRKA’s full implementation in 2022.
    Jude Balmin Jude Balmin
    Communications Lead, California Department of Public Health, California Safe Cosmetics Program (CSCP)
  12. Washington State’s Toxic-Free Cosmetics Act

    • learn about the requirements of Washington’s new law restricting nine chemicals and chemical classes in cosmetics taking effect January 1, 2025;
    • learn how to get involved in the public process underway for rulemaking to restrict chemicals that release formaldehyde in cosmetics; and
    • hear about the programs the state is implementing to assist all businesses in complying with the new law, and voluntary initiatives to assist small businesses in making and using safer products.
    Shari Franjevic Shari Franjevic
    Toxic Free Cosmetics Act Implementation Planner, Hazardous Waste and Toxics Reduction program, Washington State Department of Ecology
  13. Q&A session

  14. Lunch break for 1 hour 25 minutes

  15. Enhesa Product Intelligence service presentation and platform demo

  16. Welcome back

    Moderator

    Fourat Muziel Fourat Muziel
    Regulatory & Compliance Analyst, Enhesa Product
  17. Session 3: Finding safer alternatives for substances of concern
  18. Microbiological contamination of cosmetic products: What is the FDA doing to reduce them and what can you do?

    • learn the key factors causing microbiological contaminations - the largest cause of recalls of cosmetics products in the USA by far;
    • find out what impact MoCRA will have on the subject and the role of the FDA in enforcement; and
    • hear about the steps you need to take to reduce the risk of contaminations and the public health and business consequences of having one.
    Geoff Waby Geoff Waby
    Adjunct Professor, James L. Winkle College of Pharmacy, University of Cincinnati
  19. New sunscreen UV filters: Are there any opportunities for innovation in the US?

    • update on regulatory landscape and FDA pathways: Explore the status of FDA-approved UV filters in the US, the challenges in introducing new UV filters under the OTC Monograph system, and opportunities for innovation through Tier 1 OMOR submissions, such as Bemotrizinol;
    • consumer demand and influencer impact: Examine the growing role of consumer awareness, preferences for clean, reef-safe products, and the influence of social media in shaping sunscreen trends. Highlight how influencers and consumer advocacy can drive market demand for innovative UV filters and push regulatory change; and
    • innovative formulations and delivery systems: Discuss advancements in formulation science, including multi-functional ingredients that combine sun protection with skincare benefits like anti-aging and hydration. Explore how these innovations meet consumer desires for lightweight textures, eco-conscious solutions, and improved performance, while tapping into influencer-led product endorsements.
    Carl D'Ruiz Carl D'Ruiz
    Head of Science, Advocacy, and Business Development, dsm-firmenich Beauty Care North America
  20. Q&A session

  21. Refreshment break

  22. Session 3: Finding safer alternatives for substances of concern....cont.
  23. PFAS in cosmetics

    • PFAS 101: What are PFAS, their health harms, and why they should be treated as a class of chemicals;
    • PFAS in cosmetics: Where are PFAS used in personal care products, both as intentional/listed ingredients and accidental use/contamination;
    • Moving forward: Removing PFAS from cosmetics through business decisions & chemical regulation. 
    Dr Lydia Jahl Dr Lydia Jahl
    Senior Scientist, Green Science Policy Institute
  24. Per - and Polyfluoroalkyl Substances and alternatives in cosmetics: report on commercial availability and current uses

    Eeva Leinala Eeva Leinala
    Principal Administrator, Risk Management, Mutual Acceptance of Data and Good Laboratory Practices, Organisation for Economic Cooperation and Development (OECD)
  25. Q&A session

  26. Close of day one

View previous day

/ Next day